An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (Q87009088)
Jump to navigation
Jump to search
scientific article published on 04 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone |
scientific article published on 04 January 2016 |
Statements
An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (English)
Soo Jeong Nam
Sehui Kim
Jin Ho Paik
Tae Min Kim
Dae Seog Heo
Chul Woo Kim